Skip to main content
Erschienen in:

15.12.2017 | Review

Cognitive impairment in celiac disease and non-celiac gluten sensitivity: review of literature on the main cognitive impairments, the imaging and the effect of gluten free diet

verfasst von: Sinda Makhlouf, Mariem Messelmani, Jamel Zaouali, Ridha Mrissa

Erschienen in: Acta Neurologica Belgica | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Celiac disease (CD) and non celiac gluten sensitivity (NCGS) can be responsible for neurological complications such as ataxia and peripheral neuropathies but also cognitive impairment. This cognitive involvement is variable in its expression, its duration and its prognosis ranging from transient and reversible subtle involvement to dementia itself. Through this article, we tried to achieve a review of the literature to better understand this topic. Several mechanisms were proposed to explain the deleterious influence of gluten-related pathologies on cognitive functions: nutritional deficiencies, elevation of circulating cytokine levels due to systemic inflammation, low brain serotonin levels… Several types of dementia such as Alzheimer dementia, vascular dementia, frontotemporal dementia were reported in association with CD. Memory disorder, acalculia, inattention, visuospatial deficits and executive dysfunction must be sought systematically by a neuropsychological assessment in patients with CD or NCGS. As far as the cognitive impairment is concerned, there is no pathognomonic radiological lesion. Concerning therapeutic management; although its effect is controversial, gluten free diet should be introduced, as early as possible, because of its potentially protective effect.
Literatur
1.
Zurück zum Zitat Sapone A, Bai JC, Ciacci C, Dolinsek J, Green PH, Hadjivassiliou M et al (2012) Spectrum of gluten-related disorders: consensus on new nomenclature and classification. BMC Med 10:13CrossRefPubMedPubMedCentral Sapone A, Bai JC, Ciacci C, Dolinsek J, Green PH, Hadjivassiliou M et al (2012) Spectrum of gluten-related disorders: consensus on new nomenclature and classification. BMC Med 10:13CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Hadjivassiliou M, Rao DG, Grìnewald RA, Aeschlimann DP, Sarrigiannis PG, Hoggard N et al (2016) Neurological dysfunction in coeliac disease and non-coeliac gluten sensitivity. Am J Gastroenterol 111:561–567CrossRefPubMedPubMedCentral Hadjivassiliou M, Rao DG, Grìnewald RA, Aeschlimann DP, Sarrigiannis PG, Hoggard N et al (2016) Neurological dysfunction in coeliac disease and non-coeliac gluten sensitivity. Am J Gastroenterol 111:561–567CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Watkins RD, Zawahir S (2017) Celiac disease and nonceliac gluten sensitivity. Pediatr Clin N Am 64:563–576CrossRef Watkins RD, Zawahir S (2017) Celiac disease and nonceliac gluten sensitivity. Pediatr Clin N Am 64:563–576CrossRef
5.
Zurück zum Zitat Lionetti E, Catassi C (2011) New clues in celiac disease epidemiology, pathogenesis, clinical manifestations, and treatment. Int Rev Immunol 30(4):219–231CrossRefPubMed Lionetti E, Catassi C (2011) New clues in celiac disease epidemiology, pathogenesis, clinical manifestations, and treatment. Int Rev Immunol 30(4):219–231CrossRefPubMed
6.
Zurück zum Zitat Catassi C, Bai JC, Bonaz B, Bouma G, Calabrò A, Carroccio A et al (2013) Non-celiac gluten sensitivity: the new frontier of gluten related disorders. Nutrients 5:3839–3853CrossRefPubMedPubMedCentral Catassi C, Bai JC, Bonaz B, Bouma G, Calabrò A, Carroccio A et al (2013) Non-celiac gluten sensitivity: the new frontier of gluten related disorders. Nutrients 5:3839–3853CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Kinney HC, Burger PC, Hurwitz BJ, Hijmans JC, Grant JP (1982) Degeneration of the central nervous system associated with celiac disease. J Neurol Sci 53:9–22CrossRefPubMed Kinney HC, Burger PC, Hurwitz BJ, Hijmans JC, Grant JP (1982) Degeneration of the central nervous system associated with celiac disease. J Neurol Sci 53:9–22CrossRefPubMed
8.
Zurück zum Zitat Lebwohl B, Luchsinger JA, Freedberg DE, Green PHR, Ludvigsson JF (2016) Risk of dementia in patients with celiac disease: a population-based cohort study. J Alzheimers Dis 49:179–185CrossRefPubMed Lebwohl B, Luchsinger JA, Freedberg DE, Green PHR, Ludvigsson JF (2016) Risk of dementia in patients with celiac disease: a population-based cohort study. J Alzheimers Dis 49:179–185CrossRefPubMed
9.
Zurück zum Zitat Frisoni GB, Carabellese N, Longhi M, Geroldi C, Bianchetti A, Govoni S et al (1997) Is celiac disease associated with Alzheimer’s disease? Acta Neurol Scand 95:147–151CrossRefPubMed Frisoni GB, Carabellese N, Longhi M, Geroldi C, Bianchetti A, Govoni S et al (1997) Is celiac disease associated with Alzheimer’s disease? Acta Neurol Scand 95:147–151CrossRefPubMed
10.
Zurück zum Zitat Casella S, Zanini B, Lanzarotto F, Ricci C, Marengoni A, Romanelli G et al (2012) Cognitive performance is impaired in coeliac patients on gluten free diet: a case–control study in patients older than 65 years of age. Dig Liver Dis 44:729–735CrossRefPubMed Casella S, Zanini B, Lanzarotto F, Ricci C, Marengoni A, Romanelli G et al (2012) Cognitive performance is impaired in coeliac patients on gluten free diet: a case–control study in patients older than 65 years of age. Dig Liver Dis 44:729–735CrossRefPubMed
11.
12.
Zurück zum Zitat Bürk K, Bösch S, Müller CA, Melms A, Zühlke C, Stern M et al (2001) Sporadic cerebellar ataxia associated with gluten sensitivity. Brain 124:1013–1019CrossRefPubMed Bürk K, Bösch S, Müller CA, Melms A, Zühlke C, Stern M et al (2001) Sporadic cerebellar ataxia associated with gluten sensitivity. Brain 124:1013–1019CrossRefPubMed
13.
Zurück zum Zitat Hu WT, Murray JA, Greenaway MC, Parisi JE, Josephs KA (2006) Cognitive impairment and celiac disease. Arch Neurol 63:1440CrossRefPubMed Hu WT, Murray JA, Greenaway MC, Parisi JE, Josephs KA (2006) Cognitive impairment and celiac disease. Arch Neurol 63:1440CrossRefPubMed
14.
Zurück zum Zitat Ruuskanen A, Kaukinen K, Collin P, Huhtala H, Valve R, Mäki M et al (2010) Positive serum antigliadin antibodies without celiac disease in the elderly population: does it matter? Scand J Gastroenterol 45:1197–1202CrossRefPubMed Ruuskanen A, Kaukinen K, Collin P, Huhtala H, Valve R, Mäki M et al (2010) Positive serum antigliadin antibodies without celiac disease in the elderly population: does it matter? Scand J Gastroenterol 45:1197–1202CrossRefPubMed
15.
Zurück zum Zitat Aziz I, Hadjivassiliou M, Sanders DS (2015) The spectrum of noncoeliac gluten sensitivity. Nat Rev Gastroenterol Hepatol 12:516–526CrossRefPubMed Aziz I, Hadjivassiliou M, Sanders DS (2015) The spectrum of noncoeliac gluten sensitivity. Nat Rev Gastroenterol Hepatol 12:516–526CrossRefPubMed
16.
Zurück zum Zitat McPhedran M (2014) Identifying “brain fog”: features, triggers, and development of a psychometric tool for detection. RMIT University, Melbourne (Research) McPhedran M (2014) Identifying “brain fog”: features, triggers, and development of a psychometric tool for detection. RMIT University, Melbourne (Research)
17.
Zurück zum Zitat Murray-Kolb LE, Beard JL (2007) Iron treatment normalizes cognitive functioning in young women. Am J Clin Nutr 85:778–787CrossRefPubMed Murray-Kolb LE, Beard JL (2007) Iron treatment normalizes cognitive functioning in young women. Am J Clin Nutr 85:778–787CrossRefPubMed
18.
Zurück zum Zitat Balion C, Griffith LE, Strifler L, Henderson M, Patterson C, Heckman G et al (2012) Vitamin D, cognition, and dementia: a systematic review and meta-analysis. Neurology 79:1397–1405CrossRefPubMedPubMedCentral Balion C, Griffith LE, Strifler L, Henderson M, Patterson C, Heckman G et al (2012) Vitamin D, cognition, and dementia: a systematic review and meta-analysis. Neurology 79:1397–1405CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Forton DM, Allsop JM, Main J, Foster GR, Thomas HC, Taylor-Robinson SD (2001) Evidence for a cerebral effect of the hepatitis C virus. Lancet 358:38–39CrossRefPubMed Forton DM, Allsop JM, Main J, Foster GR, Thomas HC, Taylor-Robinson SD (2001) Evidence for a cerebral effect of the hepatitis C virus. Lancet 358:38–39CrossRefPubMed
20.
Zurück zum Zitat Senzolo M, Schiff S, D’Aloiso CM, Crivellin C, Cholongitas E, Burra P et al (2011) Neuropsychological alterations in hepatitis C infection: the role of inflammation. World J Gastroenterol 17:3369–3374CrossRefPubMedPubMedCentral Senzolo M, Schiff S, D’Aloiso CM, Crivellin C, Cholongitas E, Burra P et al (2011) Neuropsychological alterations in hepatitis C infection: the role of inflammation. World J Gastroenterol 17:3369–3374CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Addolorato G, Capristo E, Ghittoni G, Valeri C, Mascianà R, Ancona C et al (2001) Anxiety but not depression decreases in coeliac patients after 1-year gluten-free diet: a longitudinal study. Scand J Gastroenterol 36:502–506CrossRefPubMed Addolorato G, Capristo E, Ghittoni G, Valeri C, Mascianà R, Ancona C et al (2001) Anxiety but not depression decreases in coeliac patients after 1-year gluten-free diet: a longitudinal study. Scand J Gastroenterol 36:502–506CrossRefPubMed
22.
Zurück zum Zitat Ciacci C, Iavarone A, Mazzacca G, De Rosa A (1998) Depressive symptoms in adult coeliac disease. Scand J Gastroenterol 33:247–250PubMed Ciacci C, Iavarone A, Mazzacca G, De Rosa A (1998) Depressive symptoms in adult coeliac disease. Scand J Gastroenterol 33:247–250PubMed
23.
Zurück zum Zitat Choi S, Disilvio B, Fernstrom MH, Fernstrom JD (2009) Meal ingestion, amino acids and brain neurotransmitters: effects of dietary protein source on serotonin and catecholamine synthesis rates. Physiol Behav 98:156–162CrossRefPubMed Choi S, Disilvio B, Fernstrom MH, Fernstrom JD (2009) Meal ingestion, amino acids and brain neurotransmitters: effects of dietary protein source on serotonin and catecholamine synthesis rates. Physiol Behav 98:156–162CrossRefPubMed
24.
Zurück zum Zitat Hadjivassiliou M, Sanders DS, Grünewald RA, Woodroofe N, Boscolo S, Aeschlimann D (2010) Gluten sensitivity: from gut to brain. Lancet Neurol 9:318–330CrossRefPubMed Hadjivassiliou M, Sanders DS, Grünewald RA, Woodroofe N, Boscolo S, Aeschlimann D (2010) Gluten sensitivity: from gut to brain. Lancet Neurol 9:318–330CrossRefPubMed
25.
Zurück zum Zitat Dickerson F, Stallings C, Origoni A, Vaughan C, Khushalani S, Leister F et al (2010) Markers of gluten sensitivity and celiac disease in recent-onset psychosis and multi-episode schizophrenia. Biol Psychiatry 68:100–104CrossRefPubMed Dickerson F, Stallings C, Origoni A, Vaughan C, Khushalani S, Leister F et al (2010) Markers of gluten sensitivity and celiac disease in recent-onset psychosis and multi-episode schizophrenia. Biol Psychiatry 68:100–104CrossRefPubMed
26.
Zurück zum Zitat Lurie Y, Landau D-A, Pfeffer J, Oren R (2008) Celiac disease diagnosed in the elderly. J Clin Gastroenterol 42:59–61CrossRefPubMed Lurie Y, Landau D-A, Pfeffer J, Oren R (2008) Celiac disease diagnosed in the elderly. J Clin Gastroenterol 42:59–61CrossRefPubMed
27.
Zurück zum Zitat Cooke WT, Smith WT (1966) Neurological disorders associated with adult coeliac disease. Brain 89(4):683–722CrossRefPubMed Cooke WT, Smith WT (1966) Neurological disorders associated with adult coeliac disease. Brain 89(4):683–722CrossRefPubMed
28.
Zurück zum Zitat Luostarinen L, Pirttilä T, Collin P (1999) Coeliac disease presenting with neurological disorders. Eur Neurol 42(3):132–135CrossRefPubMed Luostarinen L, Pirttilä T, Collin P (1999) Coeliac disease presenting with neurological disorders. Eur Neurol 42(3):132–135CrossRefPubMed
29.
Zurück zum Zitat Lichtwark IT, Newnham ED, Robinson SR, Shepherd SJ, Hosking P, Gibson PR et al (2014) Cognitive impairment in coeliac disease improves on a gluten-free diet and correlates with histological and serological indices of disease severity. Aliment Pharmacol Ther 40:160–170CrossRefPubMed Lichtwark IT, Newnham ED, Robinson SR, Shepherd SJ, Hosking P, Gibson PR et al (2014) Cognitive impairment in coeliac disease improves on a gluten-free diet and correlates with histological and serological indices of disease severity. Aliment Pharmacol Ther 40:160–170CrossRefPubMed
30.
Zurück zum Zitat Hadjivassiliou M, Grünewald RA, Lawden M, Davies-Jones GA, Powell T, Smith CM (2001) Headache and CNS white matter abnormalities associated with gluten sensitivity. Neurology 56:385–388CrossRefPubMed Hadjivassiliou M, Grünewald RA, Lawden M, Davies-Jones GA, Powell T, Smith CM (2001) Headache and CNS white matter abnormalities associated with gluten sensitivity. Neurology 56:385–388CrossRefPubMed
31.
Zurück zum Zitat Collin P, Pirttilä T, Nurmikko T et al (1991) Celiac disease, brain atrophy, and dementia. Neurology 4:372–375CrossRef Collin P, Pirttilä T, Nurmikko T et al (1991) Celiac disease, brain atrophy, and dementia. Neurology 4:372–375CrossRef
Metadaten
Titel
Cognitive impairment in celiac disease and non-celiac gluten sensitivity: review of literature on the main cognitive impairments, the imaging and the effect of gluten free diet
verfasst von
Sinda Makhlouf
Mariem Messelmani
Jamel Zaouali
Ridha Mrissa
Publikationsdatum
15.12.2017
Verlag
Springer International Publishing
Erschienen in
Acta Neurologica Belgica / Ausgabe 1/2018
Print ISSN: 0300-9009
Elektronische ISSN: 2240-2993
DOI
https://doi.org/10.1007/s13760-017-0870-z

Kompaktes Leitlinien-Wissen Neurologie (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Neurologie

Neuartige Antikörpertherapie bremst MS über zwei Jahre hinweg

Eine Therapie mit dem C40-Ligand-Blocker Frexalimab kann MS-Schübe und neue MRT-Läsionen über zwei Jahre hinweg verhindern. Dafür spricht die Auswertung einer offen fortgeführten Phase-2-Studie.

Positive Phase IIb-Studie zu mRNA-gestützter CAR-T bei Myasthenia gravis

Eine auf das B-Zell-Reifungsantigen gerichtete mRNA-basierte CAR-T-Zell-Therapie wurde jetzt in einer ersten Phase IIb-Studie zur Behandlung der generalisierten Myasthenia gravis mit Placebo verglichen.

Therapiestopp bei älteren MS-Kranken kann sich lohnen

Eine Analyse aus Kanada bestätigt: Setzen ältere MS-Kranke die Behandlung mit Basistherapeutika ab, müssen sie kaum mit neuen Schüben und MRT-Auffälligkeiten rechnen.

Schadet Schichtarbeit dem Gehirn?

Eine große Registerstudie bestätigt, dass Schichtarbeit mit einem erhöhten Risiko für psychische und neurologische Erkrankungen einhergeht, sowie mit einer Volumenabnahme in Gehirnarealen, die für Depression, Angst und kognitive Funktionen relevant sind.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.